Back to Agenda
Trends in Biosimilars Regulation Within Developed and Emerging Markets
Session Chair(s)
Andrew Robertson, JD, PhD
Vice President, Head of Global Regulatory Policy and Innovation
Takeda Pharmaceuticals, United States
Biosimilars: Evolving Trends in the Global Scenario: Emerging Role of the Asia Pacific Region
Learning Objective : Recognize trends in biosimilar regulatory guidances within both emerging and developed markets; Identify areas of biosimilars regulation that differ between key markets.
Speaker(s)
Biosimilars: Evolving Trends in the Global Scenario: Emerging Role of the Asia Pacific Region
Sonica Sachdeva Batra, MD
Indegene Ltd., India
Associate Vice President Enterprise Medical;Global Head- Regulatory Affairs
Interdisciplinary Perspectives on Development of Naming Standards for Biosimilar Medicines
Richard Dolinar, MD
Arizona Endocrinology Center, United States
Clinical Endocrinolist
Have an account?